Does CANRENOIC ACID Cause Off label use? 24 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 24 reports of Off label use have been filed in association with CANRENOIC ACID. This represents 17.1% of all adverse event reports for CANRENOIC ACID.
24
Reports of Off label use with CANRENOIC ACID
17.1%
of all CANRENOIC ACID reports
0
Deaths
0
Hospitalizations
How Dangerous Is Off label use From CANRENOIC ACID?
Of the 24 reports.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CANRENOIC ACID. However, 24 reports have been filed with the FAERS database.
What Other Side Effects Does CANRENOIC ACID Cause?
Hyperkalaemia (33)
Toxic epidermal necrolysis (33)
Drug hypersensitivity (24)
Product use in unapproved indication (20)
Asthenia (16)
Hyponatraemia (14)
Epistaxis (13)
Dehydration (11)
Acute kidney injury (10)
Hypotension (10)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which CANRENOIC ACID Alternatives Have Lower Off label use Risk?
CANRENOIC ACID vs CANRENONE
CANRENOIC ACID vs CANTHARIDIN
CANRENOIC ACID vs CAPECITABINE
CANRENOIC ACID vs CAPIVASERTIB
CANRENOIC ACID vs CAPLACIZUMAB